Literature DB >> 17943273

Characterisation of glutamine fructose-6-phosphate amidotransferase (EC 2.6.1.16) and N-acetylglucosamine metabolism in Bifidobacterium.

Sophie Foley1, Emilie Stolarczyk, Fadoua Mouni, Colette Brassart, Olivier Vidal, Eliane Aïssi, Stéphane Bouquelet, Frédéric Krzewinski.   

Abstract

Bifidobacterium bifidum, in contrast to other bifidobacterial species, is auxotrophic for N-acetylglucosamine. Growth experiments revealed assimilation of radiolabelled N-acetylglucosamine in bacterial cell walls and in acetate, an end-product of central metabolism via the bifidobacterial D: -fructose-6-phosphate shunt. While supplementation with fructose led to reduced N-acetylglucosamine assimilation via the D: -fructose-6-phosphate shunt, no significant difference was observed in levels of radiolabelled N-acetylglucosamine incorporated into cell walls. Considering the central role played by glutamine fructose-6-phosphate transaminase (GlmS) in linking the biosynthetic pathway for N-acetylglucosamine to hexose metabolism, the GlmS of Bifidobacterium was characterized. The genes encoding the putative GlmS of B. longum DSM20219 and B. bifidum DSM20082 were cloned and sequenced. Bioinformatic analyses of the predicted proteins revealed 43% amino acid identity with the Escherichia coli GlmS, with conservation of key amino acids in the catalytic domain. The B. longum GlmS was over-produced as a histidine-tagged fusion protein. The purified C-terminal His-tagged GlmS possessed glutamine fructose-6-phosphate amidotransferase activity as demonstrated by synthesis of glucosamine-6-phosphate from fructose-6-phosphate and glutamine. It also possesses an independent glutaminase activity, converting glutamine to glutamate in the absence of fructose-6-phosphate. This is of interest considering the apparently reduced coding potential in bifidobacteria for enzymes associated with glutamine metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943273     DOI: 10.1007/s00203-007-0307-9

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  7 in total

1.  Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles.

Authors:  Samantha Coulson; Henry Butt; Phillip Vecchio; Helen Gramotnev; Luis Vitetta
Journal:  Inflammopharmacology       Date:  2012-07-22       Impact factor: 4.473

2.  Complete genome sequence of the probiotic bacterium Bifidobacterium bifidum strain BGN4.

Authors:  Dong Su Yu; Haeyoung Jeong; Dae-Hee Lee; Soon-Kyeong Kwon; Ju Yeon Song; Byung Kwon Kim; Myeong-Soo Park; Geun Eog Ji; Tae Kwang Oh; Jihyun F Kim
Journal:  J Bacteriol       Date:  2012-09       Impact factor: 3.490

3.  The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics.

Authors:  Luis Vitetta; Samantha Coulson; Anthony W Linnane; Henry Butt
Journal:  Pathogens       Date:  2013-11-14

4.  Operator recognition by the ROK transcription factor family members, NagC and Mlc.

Authors:  Dominique Bréchemier-Baey; Lenin Domínguez-Ramírez; Jacques Oberto; Jacqueline Plumbridge
Journal:  Nucleic Acids Res       Date:  2014-12-01       Impact factor: 16.971

Review 5.  Perna canaliculus and the Intestinal Microbiome.

Authors:  Emma Tali Saltzman; Michael Thomsen; Sean Hall; Luis Vitetta
Journal:  Mar Drugs       Date:  2017-06-30       Impact factor: 5.118

6.  Exploring metabolic adaptation of Streptococcus pneumoniae to antibiotics.

Authors:  Anne Leonard; Kevin Möhlis; Rabea Schlüter; Edward Taylor; Michael Lalk; Karen Methling
Journal:  J Antibiot (Tokyo)       Date:  2020-03-24       Impact factor: 2.649

7.  Differential protein profiling of soil diazotroph Rhodococcus qingshengii S10107 towards low-temperature and nitrogen deficiency.

Authors:  Deep Chandra Suyal; Divya Joshi; Saurabh Kumar; Ravindra Soni; Reeta Goel
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.